World’s first vision-restoring stem cell treatment marks major eye care breakthrough

A pioneering stem cell treatment has demonstrated potential in restoring vision for those with impaired eyesight. A study in Nature reported that three out of four patients with limbal stem-cell deficit (LSCD) experienced significant, long-lasting vision improvements after receiving transplants of reprogrammed stem cells. The treatment utilized induced pluripotent stem cells from a healthy donor, converted into corneal epithelial cells. This breakthrough could offer a new approach for treating LSCD, potentially helping numerous individuals with vision impairments.